Literature DB >> 11158992

Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis.

M Xu1, Y Wang, K Hirai, A Ayub, M Ashraf.   

Abstract

We tested the hypothesis whether calcium preconditioning (CPC) reduces reoxygenation injury by inhibiting mitochondrial permeability transition (MPT). Cultured myocytes were preconditioned by a brief exposure to 1.5 mM calcium (CPC) and subjected to 3 h of anoxia followed by 2 h of reoxygenation (A-R). Myocytes were also treated with 0.2 microM/l cyclosporin A (CsA), an inhibitor of MPT, before A-R. A significant increase of viable cells and reduced lactate dehydrogenase release was observed both in CPC- and CsA-treated myocytes compared with the A-R group. Cytochrome c release was predominantly observed in the cytoplasm of myocytes in the A-R group in contrast with CPC- or CsA-treated groups, where it was restricted only to mitochondria. Similarly, the cell death by apoptosis was also markedly attenuated in these groups. Electron-dense Ca(2+) deposits in mitochondria were also less frequent. Atractyloside (20 microM/l), an adenine nucleotide translocase inhibitor, caused changes similar to those in the A-R group, suggesting a role of MPT in A-R injury. Protection by inhibition of MPT by CsA and CPC suggests that MPT plays an important role in reoxygenation/reperfusion injury. The data further suggest that preconditioning inhibits MPT by inhibiting Ca(2+) accumulation by mitochondria.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158992     DOI: 10.1152/ajpheart.2001.280.2.H899

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  18 in total

1.  Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart.

Authors:  Sabzali A Javadov; Samantha Clarke; Manika Das; Elinor J Griffiths; Kelvin H H Lim; Andrew P Halestrap
Journal:  J Physiol       Date:  2003-04-11       Impact factor: 5.182

2.  New roles for mitochondria in cell death in the reperfused myocardium.

Authors:  Sang-Bing Ong; Asa B Gustafsson
Journal:  Cardiovasc Res       Date:  2011-11-22       Impact factor: 10.787

3.  Transduction of Wnt11 promotes mesenchymal stem cell transdifferentiation into cardiac phenotypes.

Authors:  Zhisong He; Hongxia Li; Shi Zuo; Zeeshan Pasha; Yigang Wang; Yueting Yang; Wenping Jiang; Muhammad Ashraf; Meifeng Xu
Journal:  Stem Cells Dev       Date:  2011-02-26       Impact factor: 3.272

4.  Mechanisms of chloride in cardiomyocyte anoxia-reoxygenation injury: the involvement of oxidative stress and NF-kappaB activation.

Authors:  D Liu; H He; G L Li; J Chen; D Yin; Z P Liao; L Tang; Q R Huang; Z F Lai; M He
Journal:  Mol Cell Biochem       Date:  2011-05-08       Impact factor: 3.396

Review 5.  The molecular composition of the mitochondrial permeability transition pore.

Authors:  Christopher P Baines
Journal:  J Mol Cell Cardiol       Date:  2009-02-20       Impact factor: 5.000

Review 6.  Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection.

Authors:  D Morin; R Assaly; S Paradis; A Berdeaux
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

7.  HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia.

Authors:  Ying Dai; Meifeng Xu; Yigang Wang; Zeeshan Pasha; Tingyu Li; Muhammad Ashraf
Journal:  J Mol Cell Cardiol       Date:  2007-04-06       Impact factor: 5.000

8.  Adenine nucleotide translocase-1 induces cardiomyocyte death through upregulation of the pro-apoptotic protein Bax.

Authors:  Christopher P Baines; Jeffery D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2009-06       Impact factor: 5.000

9.  Effects of acute and chronic endurance exercise on mitochondrial uncoupling in human skeletal muscle.

Authors:  Maria Fernström; Michail Tonkonogi; Kent Sahlin
Journal:  J Physiol       Date:  2003-11-21       Impact factor: 5.182

10.  Ischaemic preconditioning improves proteasomal activity and increases the degradation of deltaPKC during reperfusion.

Authors:  Eric N Churchill; Julio C Ferreira; Patricia C Brum; Luke I Szweda; Daria Mochly-Rosen
Journal:  Cardiovasc Res       Date:  2009-10-10       Impact factor: 13.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.